The American Heart Association has updated a model through which one can predict the risk of heart disease by age 30 and also predict a person’s risk to heart failure, heart attack and stroke.
The new Prevent risk calculator enables clinicians to quantify a person’s risk of cardiovascular disease and may help people receive preventive care or treatment earlier to reduce cardiovascular disease.
(Source: Pixabay)
Chicago/USA – For the first time in 10 years, the American Heart Association (AHA) has updated the model to predict someone’s risk of developing heart disease, reports a new Northwestern Medicine study published recently in the American Heart Association’s flagship journal Circulation.
The update, called Prevent (Predicting Risk of cardiovascular disease Events), predicts someone’s risk for cardiovascular disease (CVD) better and younger than before, and its race-free approach reflects the need to prioritize health equity when approaching prediction and prevention of CVD, said corresponding study author Dr. Sadiya Khan.
“The new Prevent risk calculator enables clinicians to quantify a person’s risk of CVD and may help people receive preventive care or treatment earlier to reduce CVD risk,” said Khan, the Magerstadt Professor of Cardiovascular Epidemiology and an associate professor of medicine (cardiology) and preventive medicine (epidemiology) at Northwestern University Feinberg School of Medicine and a Northwestern Medicine preventive cardiologist.
Khan also is the chair of the Scientific Statement writing group for the AHA. She will announce the findings at the AHA’s annual Scientific Sessions event in Philadelphia.
One in three U.S. adults has three or more risk factors that contribute to CVD, kidney disease and/or metabolic disorders, according to the AHA. The new equations help incorporate cardiovascular-kidney-metabolic (CKM) syndrome into CVD prevention.
The new model can predict risk of heart disease beginning 10 years younger than before (now at age 30), and estimates someone’s risk of total heart disease, which newly includes heart failure, in addition to heart attack and stroke. It also includes a measure of kidney health, which has been recognized more recently as an important risk factor for heart disease that can be managed and treated to improve health outcomes. “A new heart disease risk calculator was needed, particularly one that includes measures of CKM syndrome, the new construct defined by the AHA, which is highly prevalent in the U.S.,” Khan said.
A race-free approach, and other important updates
A risk calculator uses health, demographic and/or socioeconomic information in equations to calculate a risk estimate or score. Equations are developed by scientists based on information in national databases, large research studies and electronic health records.
The new equations remove race from their risk prediction, which the study authors said is a necessary step forward. A person’s race should not influence the diagnosis and subsequent treatment of CVD among patients. This decision follows in the footsteps of other national health associations, such as the National Kidney Foundation, which have removed race from their clinical algorithms.
Prevent uniquely quantifies risks for CVD for each biological sex. Recent research conducted specifically in women has shown women have unique differences in presentation of heart disease and the role that risk factors play.
Lastly, the equations broaden the age range for use from 30 to 79 years old (was previously 40 to 79 years old), which allows physicians to cover a greater proportion of the adult lifespan, Khan said.
The last CVD risk calculator, the Pooled Cohort Equation, was released in 2013. “However, lots of things have changed in the past 10 years, including new treatments are now available for CKM conditions such as obesity, Type 2 diabetes and kidney disease,” Khan said.
The calculator was developed using health information from more than 6 million adults, including people from diverse racial and ethnic, socioeconomic and geographic backgrounds. There is an option in Prevent to include social factors if available.
Date: 08.12.2025
Naturally, we always handle your personal data responsibly. Any personal data we receive from you is processed in accordance with applicable data protection legislation. For detailed information please see our privacy policy.
Consent to the use of data for promotional purposes
I hereby consent to Vogel Communications Group GmbH & Co. KG, Max-Planck-Str. 7-9, 97082 Würzburg including any affiliated companies according to §§ 15 et seq. AktG (hereafter: Vogel Communications Group) using my e-mail address to send editorial newsletters. A list of all affiliated companies can be found here
Newsletter content may include all products and services of any companies mentioned above, including for example specialist journals and books, events and fairs as well as event-related products and services, print and digital media offers and services such as additional (editorial) newsletters, raffles, lead campaigns, market research both online and offline, specialist webportals and e-learning offers. In case my personal telephone number has also been collected, it may be used for offers of aforementioned products, for services of the companies mentioned above, and market research purposes.
Additionally, my consent also includes the processing of my email address and telephone number for data matching for marketing purposes with select advertising partners such as LinkedIn, Google, and Meta. For this, Vogel Communications Group may transmit said data in hashed form to the advertising partners who then use said data to determine whether I am also a member of the mentioned advertising partner portals. Vogel Communications Group uses this feature for the purposes of re-targeting (up-selling, cross-selling, and customer loyalty), generating so-called look-alike audiences for acquisition of new customers, and as basis for exclusion for on-going advertising campaigns. Further information can be found in section “data matching for marketing purposes”.
In case I access protected data on Internet portals of Vogel Communications Group including any affiliated companies according to §§ 15 et seq. AktG, I need to provide further data in order to register for the access to such content. In return for this free access to editorial content, my data may be used in accordance with this consent for the purposes stated here. This does not apply to data matching for marketing purposes.
Right of revocation
I understand that I can revoke my consent at will. My revocation does not change the lawfulness of data processing that was conducted based on my consent leading up to my revocation. One option to declare my revocation is to use the contact form found at https://contact.vogel.de. In case I no longer wish to receive certain newsletters, I have subscribed to, I can also click on the unsubscribe link included at the end of a newsletter. Further information regarding my right of revocation and the implementation of it as well as the consequences of my revocation can be found in the data protection declaration, section editorial newsletter.
The CKM Health construct and Prevent risk calculator are suggested as a path forward for more holistic patient care to incorporate total CVD risk that includes heart failure as well as guidance on the use of new medications that have been shown to have benefits for reducing risks related to obesity, diabetes and kidney disease, Khan said.
The hope is that these elements will be considered and incorporated in future guideline updates.